
==== Front
Cell Commun Signal
Cell Commun Signal
Cell Communication and Signaling : CCS
1478-811X
BioMed Central London

39227829
1787
10.1186/s12964-024-01787-4
Review
Emerging roles of liquid-liquid phase separation in liver innate immunity
Zhang Xinying 1234
Yang Ziyue 12
Fu Chunmeng 12
Yao Run 13
Li Huan 13
Peng Fang pengfang@csu.edu.cn

12
Li Ning liningxy@csu.edu.cn

13
1 grid.216417.7 0000 0001 0379 7164 Department of Blood Transfusion, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan Province 410008 China
2 grid.216417.7 0000 0001 0379 7164 NHC Key Laboratory of Cancer Proteomics, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan Province 410008 China
3 grid.216417.7 0000 0001 0379 7164 Clinical Laboratory, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan Province 410008 China
4 grid.216417.7 0000 0001 0379 7164 National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, 87 Xiangya Road, Hunan Province, China
3 9 2024
3 9 2024
2024
22 43023 5 2024
11 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Biomolecular condensates formed by liquid-liquid phase separation (LLPS) have become an extensive mechanism of macromolecular metabolism and biochemical reactions in cells. Large molecules like proteins and nucleic acids will spontaneously aggregate and assemble into droplet-like structures driven by LLPS when the physical and chemical properties of cells are altered. LLPS provides a mature molecular platform for innate immune response, which tightly regulates key signaling in liver immune response spatially and physically, including DNA and RNA sensing pathways, inflammasome activation, and autophagy. Take this, LLPS plays a promoting or protecting role in a range of liver diseases, such as viral hepatitis, non-alcoholic fatty liver disease, liver fibrosis, hepatic ischemia-reperfusion injury, autoimmune liver disease, and liver cancer. This review systematically describes the whole landscape of LLPS in liver innate immunity. It will help us to guide a better-personalized approach to LLPS-targeted immunotherapy for liver diseases.

Keywords

Liquid-liquid phase separation
Biomolecular condensates
Liver innate immunity
Liver disease
http://dx.doi.org/10.13039/501100004735 Natural Science Foundation of Hunan Province 2023JJ30932 http://dx.doi.org/10.13039/501100001809 National Natural Science Foundation of China 82270633 issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcIntroduction

Cells normally perform biological functions depending on complex spatiotemporal regulation, where various biochemical reactions happen effectively and in an orderly manner in a specific time and area [1]. The membraneless organelles are subcellular compartments with high local density driven by LLPS with biological macromolecules such as proteins and nucleic acids, which are also known as biomolecular condensates [2]. LLPS plays an important role in the normal activities of life, including gene transcription and translation, chromatin organization, signal transduction, autophagy, DNA repair, cell bonding, and immune response [3]. However, despite cells have developed a variety of mechanisms to ensure the coordinated state of LLPS, the abnormal LLPS will contribute to diseases in many tissues and organs, including nerves, kidneys, lungs, intestines, and others [4–6].

Recently, LLPS has moved beyond its basic biophysical profile to be significantly correlated with immune status [7]. Innate immunity is the body’s comprehensive defense against the invasion of foreign pathogens, which uses a series of germline-encoded pattern recognition receptors to detect conserved microbial structures, including viruses, bacterial components, and endogenous damage factors released by cells. LLPS works through the dynamic recombination of molecules or isolates pathogenic agents to exactly start and amplitude immune signaling, which brings a new perspective to our understanding of immune-related diseases [8].

As a central immune organ, the liver is densely populated with Kupffer cells (KCs) and lymphocytes, such as natural killer (NK) cells, T cells, and B cells [9]. KCs are the resident macrophages in the liver, endowed with robust capabilities of antigen recognition, presentation, and phagocytic. Mitochondrial fission generates intracellular high calcium ions, inhibiting the formation of WIP/WASP droplets, KCs phosphorylate WIP and enhance the phagocytosis of tumor cells [10]. Vitro recombinant experiments have demonstrated that the intracellular domain of the CD3ε subunit of T cell receptor can undergo LLPS with Lck, which facilitates rapid T cell activation [11]. There may also be unreported LLPS droplets involved in the interaction between NK cells and their ligands during the apoptosis and ADCC of target cells.

Immune cells express multiple pattern recognition receptors (PRRs) to recognize pathogens [12]. Thus, transcription factors such as IRF3, IRF7, and NF-κB will transfer into the nucleus to activate the genes’ transcription, and then release interferon (IFN), and cytokines [13]. The dynamic changes in liver immunity caused by these molecules determine the development and evolution of liver diseases.

Therefore, we summarized the role of LLPS in cyclic GMP-AMP synthase (cGAS)- stimulator of interferon genes (STING), retinoic acid-inducible gene I protein (RIG-I)- mitochondrial antiviral signaling protein (MAVS), inflammasome pathways, and autophagy, and sorted out liver diseases based on this framework. Finally, we introduce LLPS in liver cancer and look forward to the progress of anti-tumor therapies targeting it. In short, this review provides a reliable basis for understanding of LLPS in liver innate immunity.

LLPS at a glance

The research history of LLPS

Brangwynne was the first to discover the liquid reflecting light in C. elegans embryo, also known as, P particles, which exhibit liquid-like behavior, such as dissolution, condensation, and attachment, they indicate intermolecular interaction within the cytoplasm [14]. In 2012, cryo-electron microscopy demonstrated that proteins rich in repeated charged amino acid residues and with multiple folded domains (such as the SH3 domain) contribute to LLPS [15]. In recent years, it has been approved that proteins with low complexity domain (LCD) were easier to drive LLPS through weak interactions between their amino acid residues. For example, fused fused in sarcoma (FUS) relies on tyrosine or phenylalanine residues to achieve LLPS [16] (Fig. 1).

Fig. 1 Biomolecular Condensates in eukaryotic cells. A) Schematic of the numerous condensates in the nucleus, cytoplasm, and membranes, such as stress granule, Cajal body, P-body, nuclear speckles, et al. B) Internal structure model of condensates. For example, the stress granule is driven by liquid-liquid phase separation. It is composed of proteins and RNA from the dispersed state into a highly aggregated droplet-like structure, which displays liquid-like properties

With the development of bioinformatics algorithms, more specific structures and functions of LLPS have been reported. Significantly, LLPS-regulated membraneless structures are abundant in mammalian cells [17, 18]. Nucleolus is an insoluble droplet composed of RNA and protein, which displays liquid-like viscous relaxation and effective surface tension [19]. As a self-protection mechanism for cell growth and survival, when eukaryotes face external stress, mRNA and protein are packaged into ribonucleoprotein particles, namely stress granules (SGs). When specific conditions are activated, translation can be restarted [20]. Intervention in the assembly and depolymerization of biomolecular aggregates such as SGs provide new ideas for the diagnosis of diseases (Fig. 2).

Fig. 2 Timeline of liquid-liquid phase separation (LLPS) research. The major advances in LLPS development are shown as yet

Formation conditions

Polyvalent molecules in biomolecular condensates naturally tend to aggregate into a large polymer in a heterogeneous state, similar to the layering and isolation of two phases in vinaigrettes, which reduce the solubility, thus contributing to LLPS [21]. LLPS is driven when the macromolecular components in high concentrations, exhibit a stronger affinity for each other compared to cytoplasmic molecules, and different phases are equal in chemical potentials [21, 22]. Eventually, surface tension leads to the spherical structure.

Importantly, it has been indicated that the LCD, intrinsically disordered region (IDR), and weak polyvalent interactions of the protein serve as triggers for LLPS [1]. Weak interactions, such as π-π interactions [23], cation-π interactions [24], electrostatic interactions [25], and transient cross-β contacts [26]. LLPS exhibits a remarkably dynamic and rapid ability to interact with the external environment in biomolecular condensates. Indeed, any perturbation that influences protein structures or intermolecular contacts can disturb LLPS behavior.

Exogenous infections can also evoke LLPS. Viral infection can lead to protein aggregation, which may be due to the exogenous nucleic acid molecules stimulating and attracting a substantial quantity of antiviral immune molecules. For instance, heat shock proteins are frequently integrated into virions via LLPS to facilitate the assembly and enhance the proteins’ stability [27].

Regulation methods

Physicochemical property and post-translational modification (PTM) regulate LLPS

The alteration of physical and chemical properties is the fundamental element for LLPS, such as component concentration, temperature, pH, valency, salt concentration, and PTM of proteins, like phosphorylation, methylation, ubiquitination, acetylation, etc. [28, 29]. Proteomic analysis has successfully identified a total of 14 serine or threonine phosphorylation sites on LCR [26, 30]. Sang has shown that the C-terminal fragment of MAPK3 will accelerate the serine site phosphorylation of substrate ELK1 after recruitment. This finding suggests that the condensate itself can modulate the new links in the LLPS network by increasing the phosphorylation rate [31]. Furthermore, the methylation of arginine residues can enhance the hydrophobic properties of RNA-binding proteins, like FUS, consequently impeding LLPS.

PTMs are closely associated with a variety of diseases, including cardiovascular disorders, liver diseases, and neurological disorders [32]. They play a crucial role in coordinating gene expression, metabolic reprogramming, and immune recognition. Deviations in these modification levels can lead to genomic abnormalities, cellular metabolic disruptions, and immune evasion [33]. Consequently, PTMs influence LLPS by changing the charge distribution and hydrophobicity of key protein IDRs, which encompasses both up-regulation and down-regulation, further impacting disease progression.

Certain core molecules regulate LLPS

LLPS is regulated by several “switch” molecules including GAP SH3 Binding Protein 1 (G3BP1), G3BP2, ATP, etc. Cells can produce SGs to protect themselves from damage under stress [34]. As a structural composition of SGs, G3BP1 possesses a nuclear transport 2-like domain, an inherently disordered region, and an RNA binding domain that contains RNA-recognized and RGG motifs. Under no-stress conditions, G3BP1 is in a closed conformation [35]. Under external stimulation, an elevated RNA in the cell induces RNA-dependent LLPS, causing a change into an open G3BP1 conformation. During this, the RGG domain binds to RNA, and phosphorylation occurs at S149, which promotes LLPS [36]. Further studies have revealed that the interaction between Caprin1 and G3BP1 with NTF2 can enhance the formation of SGs. Conversely, USP10 acts as a negative regulator of SGs assembly by obstructing the binding site of NTF2 [37]. In addition, it has been confirmed that ATP can also promote LLPS, for example, free nucleotides promote the formation of droplets in nucleosomes within H1 chromatin. This finding highlights the potential role of energy molecules in LLPS regulation [38]. Recently, 1,518 endogenous phase-separating proteins have yet to be discovered in a quantitative and high-throughput manner [39]. Therefore, we look forward to more factors involved in LLPS assembly to develop precise molecular targets.

The physiological function of LLPS

Gene transcription and protein translation

The core proteins involved in transcriptional activation are formed through LLPS aggregation, including RNA polymerase II, transcription factors, coactivators, and elongation factors [40]. During transcription initiation, LLPS recruits Pol II to gather at active gene sites and enhances concentration between DNA and transcription factors to form the transcription initiation complex [41]. During transcription elongation, the C-terminal domain of Pol II is phosphorylated by the transcription elongation factor P-TEFb, and aggregates with other proteins, ultimately leading to complete the transcription [30]. Interestingly, super-enhancers are formed by transcription factors and co-activators through LLPS, which may provide insights into the excessive activation of tumor genes [42] (Fig. 3).

Fig. 3 LLPS is involved in a wide range of physiological functions, including gene transcription, protein translation, chromatin structure organization, signal transduction, cell-cell tight junctions, autophagy, and DNA damage repair

Translating RNA into proteins also requires LLPS. Recent studies have provided evidence that ATXN2 facilitates the translation of the circadian rhythm protein PER2 through binding within its AUUUU/A motif in RNA [43]. This finding opens a novel perspective for future investigations into the trans-spatial and temporal regulation of diverse cellular activities via LLPS [44] SGs is conducive to cell survival [45]. In virus-induced stress response, the cell’s protein translation is inhibited. At the same time, eukaryotic initiation factor 2α kinase in SGs can efficiently activate NF-κB and IRF3 on the innate immune signaling pathway, which recruits antiviral proteins and initiates antiviral response [46].

Chromatin organization

Chromatin is a condensed and organized structure composed of histones and DNA. LLPS plays a crucial role in chromatin compartmentalization [47]. Protein purification experiments initially revealed that heterochromatin protein 1 (HP1) possesses the capability to create LLPS droplets, and it will be considerably diminished when lysine is substituted with an uncharged amino acid [48]. Furthermore, HP1 is more prone to form droplets when interacting with single-stranded DNA compared to double-stranded DNA [49]. Another study found that methyl-CPG binding protein 2 can induce LLPS in vitro and compete with histone HP1 to generate chromatin condensates. Besides, the binding of methyl-CPG protein 2 to DNA makes it easier to form chromatin condensates [50, 51].

Signal transduction

Various signaling pathways rely on LLPS, such as RTK, Hippo, JAK-STAT3, and mTOR signaling pathways. The RTK signaling pathway depends on the phosphorylation of a terpolymer complex, which contains fibroblast growth factor receptor 2, the phosphatase SHP2 and PLCγ1. It serves as a scaffold to interact with downstream molecules on the plasma membrane [52, 53]. In the Hippo signaling pathway, the core protein kinase LATS2 forms a condensate and recruits important components to promote signaling activation and the cells’ apoptosis [54].

LLPS exists in the synaptic transmission. The postsynaptic density is a membraneless structure located beneath the postsynaptic plasma membrane and is characterized by proteins in high concentrations, where the cognitively deficient synaptic-associated protein SynGAP interacts with PSD-95 via LLPS [55, 56]. In conclusion, the optimal level of LLPS is necessary for transmission within cellular systems.

LLPS in liver innate immune signaling pathways

cGAS-STING pathway

The cGAS-STING pathway is robust in DNA sensing and innate immune response [57]. Following viral infection and cellular damage, there is a notable increase in DNA concentration within the cytoplasm. Subsequently, a cGAS-dsDNA complex is created into a high-concentration droplet via LLPS, which induces the catalytic domain rearrangement of cGAS, ultimately leading to the synthesis of cyclic GMP-AMP (cAMP). In the resting state, STING is primarily localized in the ER [58]. Upon binding of the cyclic GMP-AMP (cGAMP), it performs a conformational change and transfers to the Golgi apparatus. In fact, the translocation event is accompanied by post-translational modifications and subsequent activation of TBK1. Then, IRF3 recruited by STING will be phosphorylated by TBK1, then translocating into the nucleus as a dimer to regulate the transcription of type I IFN [59, 60]. (Fig. 4) At present, nanoparticle-delivered Svg3 has shown great potential as a cGAS agonist oligonucleotide in cancer combination immunotherapy [61].

Fig. 4 Schematic model of cGAS-STING and RIG-I-MAVS signaling pathway via LLPS. After sensing and recognizing DNA from itself or viruses, cGAS will combine with DNA and assemble into a complex. The cGAS-DNA droplets activate cGAMP, which further binds to STING on the endoplasmic reticulum membrane and activates the STING-TBK1-IRF3 axis, eventually inducing type I IFN expression. After DNA viral infection, RIG-I will detect RNA quickly. When binding to the K63 polyubiquitin chain, RIG-I interacts with MAVS through their CARD domain. Subsequently, a fraction of MAVS molecules will undergo initial aggregation via LLPS, and then more MAVS molecules form a large condensate, which triggers the RIG-I signal cascade and causes the activation of NF-κB, resulting in the type I IFN expression. Too high concentration of cGAMP can induce STING to pull ER together and form a cubic membrane-like structure, which hinders downstream signal transduction [62]. Obviously, cells regulate the cGAS-STING pathway through LLPS to maintain the optimal level of innate immunity, which enables cells to effectively counteract external pathogens while safeguarding their own tissues from harm. ATP: adenosine triphosphate; GTP: guanosine triphosphate; cGAS: cyclic GMP-AMP synthase; cGAMP: cyclic GMP-AMP; STING: stimulator of interferon genes; TBK1: TANK-binding kinase 1; IKK: inhibitor of kappa B kinase; IRF3: interferon regulatory factor 3; NF-kB: nuclear factor kappa-B; RIG-I: retinoic acid-inducible gene I protein; MAVS: mitochondrial antiviral signaling protein; CARD: caspase activation and recruitment domains

RIG-I-MAVS pathway

RIG-I is an RNA sensor in the innate immune response. It is expressed not only in immune cells but also in hepatocytes [63]. As an adapter protein in the downstream signal transduction, MAVS interacts with RIG-I by their caspase activation and recruitment domains (CARDs). Additionally, MAVS possesses a short transmembrane domain at its C-terminal region responsible for anchoring itself to the mitochondria membrane [64]. In virus-infected cells, RIG-I detects viral RNA, and upon binding to the K63 polyubiquitin chain, RIG-I combines with MAVS. A fraction of MAVS molecules undergoes initial aggregation via LLPS, followed by subsequent recruitment of more MAVS molecules to form larger condensates. It triggers the RIG-I signal cascade and leads to the activation of NF-κB and IRF3, resulting in the type I IFN gene expression [65]. Therefore, the balance of RIG-I-MAVS is crucial in liver diseases, especially those caused by concomitant viral infections.

Inflammasome pathway

Inflammasome is a polymeric protein complex that triggers inflammation in response to exogenous pathogens or endogenous danger signals. This complex is composed of a sensor (a member of the NLR family), an adaptor protein (apoptosis-associated speck-like protein), and an effector protein (procaspase-1) [66]. In liver disease, the NLR family involved in inflammasome includes NLRP1, NLRP3, NLRP6, NLRC4, and AIM2 [67]. In the canonical inflammasome pathway, the inflammasome promotes the secretion of IL-1β, IL-18, and IL-33, and causes a systemic or local inflammatory response to initiate pyroptosis [68].

Fluorescence recovery after photobleaching has found that dsRNA can induce NLRP6 with multiple repeated lysines to emerge LLPS in vitro. NLRP6-dsRNA droplets are highly dynamic, and a hepatitis virus-infected mice model further confirmed the NLRP6 condensates in vivo [69]. It explains that LLPS acts as a switch to start the inflammatory response so that it integrates various signals and resists the external virus attack in an orderly manner.

Autophagy

Autophagy is an ancient innate immune homeostatic process that clears cytoplasmic protein aggregates or engulfs extracellular debris through mitochondria and lysosomes [70]. Theoretically, autophagy possesses anti-inflammatory functions [71]. It can degrade liquid condensates, and the pre-autophagosomal structure also undergoes LLPS to regulate autophagosome [72]. Studies have shown that LLPS is involved in selective autophagy, where droplets containing p62 and receptor proteins determine the direction of the isolation membrane extension [73]. Droplet-like p62 can recognize polyubiquitin chains on target proteins, which then recruit autophagy-related proteins such as ATG8 to form autophagosomes, thereby promoting autophagic degradation [74]. Clinically, this mechanism has been confirmed to provide protective effects against Huntington protein-induced cell death [75]. p62 is a common component of many disease-associated cellular inclusions, such as Mallory-Denk bodies, which are present in alcoholic hepatitis and alcoholic cirrhosis patients. Therefore, specifically targeting and degrading pathogenic proteins in the liver by controlling linker protein LLPS appears to be a promising and innovative therapeutic strategy.

Research indicates that dysregulation of autophagy is associated with various liver diseases [76]. Intracellular proteins can condense into LLPS droplets under certain physicochemical conditions. These cytotoxic protein aggregates are selectively degraded via autophagy. For instance, autophagy intersects with lipid homeostasis, where lipid droplets may mediate the breakdown through LLPS, thereby providing energy for the liver [77].

Liver innate immunity and diseases

Emerging evidence extends that overactivated innate immunity may contribute to liver disorders, including viral hepatitis, non-viral hepatitis, non-alcoholic fatty liver disease (NAFLD), liver fibrosis, liver ischemia-reperfusion injury (IRI), autoimmune liver disease (ALD), and liver cancer [78]. Therefore, we aim to artificially manipulate the strength of the liver’s innate immunity utilizing the regulatory law of LLPS (Fig. 5) (Fig. 6) (Table 1).

Fig. 5 A model of liver diseases with innate immune inflammation as the central link. The liver is an immune organ with abundant innate immune cells including kupffer cells and natural killer cells. Hepatic stellate cells and endothelial cells are also involved in liver innate immunity. This induces inflammation and promotes the production of many inflammatory cytokines, which contribute to various liver diseases as shown in the figure. IFN: Interferon; IRF3: interferon regulatory factor 3; TNF: tumor necrosis factor; ROS: reactive oxygen species

Fig. 6 A pattern diagram of LLPS involvement in different liver constituent cells. The liver is an immune organ composed of various cells, including hepatocytes, Kupffer cells, epithelial cells, hepatic stellate cells, and immune cells (e.g. NK cells, T cells, and B cells). Hepatocytes contain abundant LLPS, including cccDNA, p62, NLRP6, glycogen molecules, and MAVS-STING. KCs contain lncRNA MALR-ILF3 and phagocytic protein WIP/WASP droplets. Different cells perform specific physiological functions to maintain homeostasis or impact disease progression driven by LLPS. cGAS: cyclic GMP-AMP synthase; LLPS: liquid-liquid phase separation; NK: natural killer; SG: stress granules; STING: stimulator of interferon genes; TNFα: tumor necrosis factor-α; DDX3X: DEAD-box helicase; cccDNA: covalently closed circular DNA; p62: Sequestosome 1; ATG8: autophagy-related proteins; Keap1: kelch like ECH associated protein 1; Nrf2: nuclear factor-erythroid 2-related factor 2; WASP: Wiskott–Aldrich syndrome protein; WIP: WASP-interacting protein; MALR: mammalian apparent long terminal repeat (LTR) retrotransposons; ILF3: interleukin enhancer binding factor 3; HIF1α: hypoxia-inducible factor 1α; NLRP3: NOD-like receptor family pyrin domain containing 3

Table 1 The involvement of LLPS in liver constituent cells

Liver constituent cells	The involvement of LLPS	
Hepatocyte	cccDNA undergoes LLPS in a G-quadruplex-dependent manner to promote its propagation in hepatocyte [87]	
DDX3X protects against drug-induced liver injury by controlling SGs formation [95]	
p62 undergoes LLPS with the core autophagy-related protein ATG8, then Keap1 is reversibly sequestered in the p62 droplet to activate the transcription factor Nrf2 [96]	
dsRNA induces NLRP6 to LLPS, which activates inflammasomes for antiviral immune responses [69]	
Excessive accumulation of glycogen can inhibit Hippo signaling activity through LLPS, thereby driving tumorigenesis [97]	
HBV polymerase disrupts K63 ubiquitination of STING and interacts with STING to inhibit immune responses [79]	
HCV NS4B directly binds to STING, which weakens the interaction between STING and TBK1 to block interferon signal transduction [82]	
NS4B competitively binds to MAVS, blocking the interaction between STING and MAVS, strongly inhibiting MAVS-mediated phosphorylation of IRF-3 [82]	
STING interacts with mitochondrial proteins Bcl-2 and Bax to activate the mitochondrial apoptosis pathway, which causes hepatocyte apoptosis and upregulates inflammatory pathways [94]	
Kupffer cell	HBV core activates the cGAS-STING signaling pathway in Kupffer cell through TLR2, it inhibits T cell responses by producing IL-10 [80]	
The activation of STING promotes the production of TGF-β1, which further induces the activation of hepatic stellate cell [98]	
Iron death from hepatocytes or mtDNA leakage will stimulate STING to promote fibrosis [99]	
The secreted TNFα can stimulate cancer cells to upregulate lncRNA MALR, which enhances LLPS of the MALR-ILF3-HIF1α axis, thereby promoting cancer progression [100]	
Intracellular high calcium ions from mitochondrial fission inhibit the formation of WIP/WASP droplets, which makes WIP more susceptible to be phosphorylated, thereby increasing macrophage phagocytosis of tumor cells [10]	
Liver sinusoidal endothelial cell	Activation of the cGAS-STING promotes the formation of sinusoidal microthrombi in the liver, which increases portal vein pressure [101]	
The activated cGAS-STING inhibits endothelial cell proliferation and alleviates liver fibrosis [102]	
Hepatic stellate cell	Galectin 3 activates NLRP3 inflammasome in Kupffer cell and hepatic stellate cell to drive primary biliary cholangitis [103]	

Viral hepatitis

Viral hepatitis is an infectious disease caused by multiple hepatitis viruses, the most common being hepatitis B virus (HBV) and hepatitis C virus (HCV). The strength of the antiviral immune response depends on the LLPS in the immune pathway [79, 80]. The cGAS-STING pathway and hepatitis virus infection are interdependent. On the one hand, by recognizing nucleic acid components, cGAS-STING prevents viral replication by initiating downstream inflammatory factors [81]. On the other hand, hepatitis viruses evade the cGAS sensing by employing many tactics. For example, the hepatitis B virus X protein (HBx) directly stimulates the ubiquitination and autophagic degradation of cGAS, which down-regulates the production of type I IFN [82]. HCV disrupts the interaction between STING and TBK1 by NS4B proteases to inhibit RNA-induced IFN activation [83].

RIG-I targeting activation has been confirmed as a new treatment for viral hepatitis. The long-term existence of cccDNA in the hepatocyte nucleus is typical for chronic HBV hepatitis [84]. RIG-I agonists can effectively resist cccDNA by activating immune responses [85]. In a study, the co-delivery of siRNA targeting HBx and IL-12 plasmid to hepatocytes upregulates MAVS and RIG-I, thereby reversing virus-induced immune suppression [86]. Interestingly, cccDNA undergoes LLPS in a G-quadruplex-dependent manner, which accelerates HBV propagation within liver cells. This suggests that disrupting the stability of G4 structures may offer a potential strategy to alleviate chronic infections [87]. In HCV-infected hepatocytes, the expression of RIG-I and MDA5 is significantly decreased compared with other PRRs, which reveals that signal amplification of RIG-I-MAVS may serve as a crucial target for antiviral immunotherapy [88]. It is worth noting that HCV uses innate pathways to exploit its infectious advantage, thereby promoting HCV self-assembly and hepatic lipogenesis [89].

Both HBV and HCV infections impair autophagic flux [90, 91]. The HBx and HCV NS5B enhance the autophagosome formation in liver cells [92]. HBx reduces lysosomal targeting by interacting with V-ATPase, thereby impairing autophagic degradation. On the other hand, HCV defects autophagic flux by disrupting the fusion of autophagosomes with lysosomes [93]. Therefore, autophagy can serve both as an antiviral defense mechanism and as a process that supports viral replication.

Non-viral hepatitis

Non-viral hepatitis refers to a group of hepatitis mainly including steatohepatitis, alcoholic hepatitis, and drug-induced liver injury (DILI) [94]. Continuous and prolonged hepatic cellular oxidative stress and liver inflammatory stimuli are key signatures of DILI. Excessive acetaminophen can promote the production of reactive oxygen species (ROS) and induce mitochondria to release mtDNA, thus activating the cGAS-STING [104]. Hepatocyte DDX3X protects against DILI by controlling SGs formation and oxidative stress [95]. Acetylation of the IDR region in DDX3X is essential for enhancing LLPS propensity and SG maturation. The deacetylase SIRT6 is a critical regulator of SGs [105]. Therefore, specific acetylation modifications are closely associated with liver diseases.

Autophagy can protect against DILI by selectively removing damaged mitochondria and drug conjugates. For example, chlorpromazine alleviates DILI by activating autophagy [106]. Additionally, IL-22 prevents DILI in mice by activating AMPK-dependent autophagy [107]. Therefore, targeted autophagy presents an effective strategy for the prevention of DILI.

NAFLD

NAFLD is the most common chronic liver disease worldwide [108]. For example, a high-fat diet can activate the cGAS-STING response in adipose tissue, further leading to obesity, insulin resistance, and metabolic dysfunction [109]. Immunohistochemistry has shown that STING levels in hepatocytes of NAFLD are higher than those of non-NAFLD. On the contrary, loss of STING in macrophages mitigates hepatic steatosis and reduces serum levels of cholesterol, triglycerides, and low-density lipoproteins [110, 111]. In addition, lipid overload in hepatocytes leads to replication stress and DNA damage, which stimulates specific upregulation of cGAS-STING [112]. These suggest that the inflammatory response and the lipid metabolism disorder are mutually reinforcing.

The dysregulated immunity contributes to the transformation of non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH) [113]. Immunohistochemical analysis of the human liver has shown that the RIG-I level of advanced NASH is significantly stronger than that of NAFL, besides, the mean IRF3 staining intensity in NASH bile duct is higher than that in NAFL [114]. The RIG-I-MAVS pathway plays a contributing role in the deterioration of NAFLD.

Autophagy serves as a protective mechanism against lipid toxicity in NAFLD. However, hepatic autophagy and lysosomal function are compromised in disease states, leading to more severe pathogenic steatosis [115, 116]. In hepatocytes, p62 and ATG8 form autophagosomes, and subsequently, Keap1 can bind within the p62 gel reversibly, activating the transcription factor Nrf2 [116] These findings suggest that p62 gels may function as a platform for Nrf2-mediated inflammatory responses. Further research is needed to elucidate the role of LLPS-mediated selective autophagy in liver diseases. Additionally, it is worth exploring whether enhancing liver lipid droplet clearance through the ubiquitin-proteasome system via LLPS could be a viable strategy.

PTMs are involved in NAFLD. A study indicates that acetyl-CoA helps limit the autophagic degradation of lipid droplets, acting as a key regulator of hepatic lipid homeostasis [117]. Evidence shows that deacetylase SIRT3 is reduced in NAFLD [118]. Additionally, the phosphorylated insulin-induced gene weakens its interaction with the E3 ubiquitin ligase gp78, thereby inhibiting hepatic lipogenesis [119]. Therefore, inhibiting acetyl-CoA production or modulating specific acetylation/ubiquitination in the liver could be a novel therapeutic option for NAFLD.

Liver fibrosis

In the process of chronic liver disease, excessive deposition and abnormal distribution within the extracellular matrix in the liver will lead to fibrosis. The activated KCs and hepatic stellate cells (HSCs) are the core pathogenesis of hepatic fibrosis [120, 98]. For example, X-box binding protein 1 can promote the mtDNA leakage from KCs and induce innate immunity [121]. Iron death in hepatocytes will cause oxidative DNA damage and stimulate STING in KCs, which establishes an activated immune microenvironment to promote liver injury and fibrosis [99]. Accordingly, the upregulation of cGAS-STING has been reported to aggravate liver inflammation in liver fibrosis patients and mice models [101]. However, activated cGAS-STING can inhibit endothelial cell proliferation, thus showing the potential to alleviate liver fibrosis [102]. To sum up, there is still controversy regarding the aggravating or mitigating effects of the cGAS-STING pathway on liver damage, and whether these effects are dominant in specific situations subject to further consideration.

Autophagy promotes HSC activation. In vitro studies have shown that autophagic activity significantly increases in fibrous mouse or human HSCs [122]. Various signaling pathways can activate autophagy in HSCs to promote fibrosis, such as the Akt/mTOR, ERK, and JNK pathways [116]. Additionally, p62 can directly bind to the vitamin D receptor and retinoid X receptor, urging their heterodimerization and thereby suppressing HSC activation [123]. Therefore, the accumulation of p62 due to autophagy inhibition may inhibit liver fibrosis through LLPS.

Liu ZY demonstrated that phosphorylation of heat shock protein 27 under stress enhances FUS LLPS, maintaining a liquid phase to prevent amyloid fibril formation [124]. Although no specific molecules have been identified that undergo spontaneous LLPS in liver fibrosis, it is possible that PTMs crosstalk-induced protein aggregation changes may occur in the context of complex stress disorders and extensive protein deposition.

IRI

IRI, manifested by innate immune-mediated inflammation and stress-induced oxidative damage, usually occurs after hepatectomy and liver transplantation, leading to liver dysfunction and transplant failure [125]. Hepatocytes release significant mtDNA during IRI, it will be recognized by cGAS-STING and contribute to the production of inflammatory cytokines, thus aggravating IRI [126]. Notably, cGAS-mediated autophagy can protect the liver in a STING-independent manner [127]. So, the localization pattern of STING in different cells, and the tissue specificity of cGAS-STING pathway both remain to be explored.

Previous studies have found that ROS secreted by IRI contributes to the MAVS activation and further LLPS aggregation in vivo, which finally excites downstream inflammatory pathways [128]. Paradoxically, new experiments demonstrated that reduced MAVS expression can enhance apoptosis and mitophagy in IRI, accompanied by higher plasma alanine aminotransferase and tumor necrosis factor-α [129]. It indicates a protective role for MAVS in liver inflammation.

ALD

ALD is a special chronic liver disease caused by immune dysfunction, including autoimmune hepatitis (AIH), primary biliary cholangitis, and primary sclerosing cholangitis (PSC). Droplets formed by cGAS and DNA inhibit the nuclease TREX1, this limits self-DNA degradation and leads to immune overactivation, finally resulting in AIH [130] In the AIH mice model, overload manganese establishes a hepatic inflammatory microenvironment and aggravates liver injury by activating the cGAS-STING pathway [131]. Drugs targeting the LLPS of cGAS-DNA may offer a valid treatment for AIH and other autoimmune diseases. However, the cGAS-STING pathway in other ALDs is rarely reported.

The dual role of NLRP3 inflammasomes in PSC has been confirmed. On the one hand, by releasing inflammatory factors to increase liver injury and fibrosis. For example, studies have shown that galectin 3 can activate NLRP3 inflammasome in KCs and HSCs to drive primary biliary cholangitis [103]. On the other hand, blocking other cell death pathways protects the PSC during acute cholestasis liver damage [132]. It can be seen that the innate immune and the cell death pathways interact to affect the balance of liver disease states.

Liver cancer

Liver cancer is a primary malignant tumor derived by persistent chronic liver damage, inflammation, and compensatory hyperplasia [133]. cGAS-STING recruits immune cells to gather and clear cancer cells by enhancing their susceptibility to immune attack by NK cells and CTLs [134]. Currently, STING agonists are used as adjuvants in cancer vaccines by activating anti-tumor immunity [12]. Interestingly, the activation of the intrinsic cGAS-STING pathway in cancer cells also mediates immune cloaking after radiation therapy-induced DNA damage [135].

We consider RIG-I as a tumor suppressor, and overloaded RIG-I expression will be against proliferation, migration, and invasion of cancer cells [136]. A study found that in the diethylnitrosamine-induced HCC development model, the demethylase JMJD4 can demethylate RIG-I and prevent the IL-6-STAT3 signaling pathway to impair anti-tumor immunity. In other words, reduced RIG-I in carcinoma progenitor cells drives progression from HcPC to HCC [137]. It should be pointed out that RIG-I binds with STAT to amplify the IFN reaction in the above study [63]. Therefore, whether RIG-I has crosstalk and additional effects between the two pathways in viral HCC still needs to be verified.

Autophagy inhibits tumors, and defects in autophagy can promote liver cancer. The activation of oncogenes or loss of tumor suppressor genes can lead to mTORC1 activation [138]. Dysregulation of the p62-Keap1-Nrf2 axis has been observed in human and mouse HCC. The increased Keap1-p62 aggregates are associated with improved liver function [96]. Therefore, accelerating early autophagosome formation and autophagic protein aggregation through LLPS could be a potential therapeutic approach to liver cancer.

PTMs play a crucial role in cancer progression. N6-methyladenosine exerts biological effects by dynamically regulating methylation levels, including immunity, tumorigenesis, and adipogenesis [139]. The coiled-coil (CC) domain of the ubiquitin ligase RNF214 promotes the growth and migration of HCC through LLPS [140]. Additionally, SIRT1 is overexpressed in HCC, it promotes HCC in an obesity-dependent manner and involves crosstalk with mRNA methylation, protein acetylation, and ubiquitination [141]. Thus, PTMs of proteins or RNA influence their biomolecular aggregation through LLPS and may serve as biomarkers for early diagnosis of liver cancer.

Biomolecular condensates in liver cancer

LLPS enhances oncogenic signaling pathways and advances cancer progression, and has been proposed as a promising cancer biomarker and intervention target. In addition to the above-mentioned pathways, biomolecular condensates formed by other molecules are present in liver cancer [100].

Crafty tumors take advantage of LLPS as a strategy to evade innate immunity. For example, the cells’ growth needs more glucose consumption, when LLPS occurs in sufficient glycogen, the Laforin-Mst1/2 complex is wrapped together, which jointly activates the oncoprotein Yap, leading to liver growth and tumor transformation [97]. Recent evidence revealed that the acetyltransferase KAT8 and IRF1 will form a droplet and localize to the PD-L1 promoter, prompting the transcription and expression of PD-L1 [142]. In addition, the fusion oncoprotein PKA, which is linked to atypical liver cancer, can effectively block cAMP LLPS and result in abnormal signaling [143]. There are many other mutant proteins that improve the survival advantage and chemotherapy resistance of tumor cells by disrupting LLPS, such as tumor suppressor factors SPOP, [144]. PTEN, [145]. USP42 [146], . and SHP2 [15].

LLPS has also been observed to exert an anti-tumor effect. RNA interference technology demonstrated that circVAMP3 acts as a molecular scaffold by facilitating the LLPS assembly of SGs with CAPRIN1. This subsequently suppresses cancerous proliferation and migration [147].

Anti-tumor therapy focused on LLPS

Abnormal LLPS are regarded as carcinogenic factors. At present, studies have confirmed that LLPS is involved in a variety of cancers by condensing oncoproteins and changing chromatin structure, such as liver cancer, lung cancer, kidney cancer, ovarian cancer, leukemia, etc. [148]. Therefore, this section discusses anti-tumor efforts focused on the whole cancers, not limited to HCC [149]. The application of single-molecule magnetic resonance, atomic force microscopy, and freezing electron microscopy, along with the LLPS protein database PhaSepDB have provided us with great convenience to deepen the understanding of LLPS [150, 151].

The fusion protein is a prevalent mechanism that LLPS contributes to cancer progression. Scientists developed a high-throughput screening technique known as DropScan to find compounds that can regulate abnormal LLPS condensates. It offers a wide possibility for cancer treatment by targeting condensate fusion protein [152]. Recently, a series of chemical probes have been developed that exhibit binding affinity sensitive to the LLPS microstructure, enabling visualization, quantitative analysis, and even manipulation [153].

Certain antitumor medications also can engage in agglomerate assembly. Wang et al. have revealed that adriamycin exhibits specific binding to histone HP1. It induces an overall conformational change via LLPS, which suggests the latent role of LLPS in boosting drug enrichment at specific sites [154].

Concluding remarks and future perspectives

In a word, LLPS provides a new perspective on innate immune-mediated liver diseases. Our study comprehensively elaborates on the innate immune signaling pathways and pathological mechanisms of various liver diseases based on LLPS. Furthermore, we highlight the potential significance of LLPS in anti-tumor immunity and therapy techniques targeting it.

From viral hepatitis or NAFLD to liver fibrosis, and further to cirrhosis and cancer, it is worth noting that the immune signaling runs through the whole process of liver diseases. Under healthy conditions, hepatic immune cells maintain tolerance to circulating antigens and endotoxins. In response to external stimuli, the liver can rapidly induce the accumulation and infiltration of immune cells, while simultaneously triggering autoimmune inflammation which in turn leads to organ damage [155].

Cells infected with hepatitis viruses are primarily exposed to persistent signaling mediated by NK cells, NKT cells, and KCs, leading to chronic liver inflammation. In NAFLD, excessive lipotoxicity continuously assaults innate immune cells, promoting persistent TLR signaling. Under oxidative stress, KCs differentiate into pro-inflammatory macrophages, producing large amounts of interleukins (IL-1β, IL-12, IL-23), leading to NASH, liver damage, and insulin resistance [156]. In alcoholic hepatitis, ethanol overload drives KCs and CD4 + Th cells to secrete large amounts of IL-17, which collectively sustains liver inflammation [157]. Subsequently, the liver immune microenvironment stimulates HSCs to transform into a proliferative and fibrogenic phenotype, upregulating collagen synthesis activity and resulting in liver fibrosis [155]. This progressively worsens parenchymal damage, potentially advancing to late-stage cirrhosis and liver cancer. LLPS has been shown to be involved in immune signaling pathways and autophagy in various liver constituent cells. Consequently, immunotherapy, particularly immune checkpoint inhibitors, shows promise in the management of liver diseases [158]. In HCC, activated RIG-I is necessary for immune checkpoint blockade to exert anti-tumor efficacy, which poses a higher challenge for us to balance immunity as a therapeutic target [159]. Therefore, a better understanding of LLPS-related immune dysregulation is essential to advance precision immunotherapy for liver disease.

It is predicted that more than 30% of the human proteome tends to form LLPS condensates [160]. We should pay attention to the altered physicochemical properties of LLPS in liver diseases. For example, biomolecular condensation can be affected by the stiffness of the surrounding matrix. In liver fibrosis, excessive deposition of diffuse extracellular matrix will lead to increased hardness, which may alter the agglomerates assembly. Abnormal glycolipid metabolism or cellular damage may also affect LLPS by changing pH and osmotic pressure in the liver [161].

We hope to improve the disease state by regulating the local strength of liver immunity through LLPS. However, it is important to acknowledge that our research has certain limitations inevitably. First, the relevant literature was indeed limited about the involvement of LLPS itself in liver diseases, and we did our utmost to utilize the available resources to support our conclusions. We will continue to explore future research to enhance the comprehensiveness and scientific rigor of our study. Additionally, many experiments are only conducted in vitro or in animal models, which limits the application to clinical treatment [151, 153]. Even though several drugs have been designed to disrupt condensates, their suitability still requires further verification. Furthermore, the strategies for preventing viral and tumor cells’ off-target still need more investigations.

Finally, we still hope that scientists will continue to contribute valuable insights and make significant advancements in clinical medicine, thereby paving the way for a new pattern on LLPS.

Acknowledgements

Not applicable.

Author contributions

Conceptualization and writing: Xinying Zhang, Ziyue Yang. Figures organization: Xinying Zhang, Huan Li, Chunmeng Fu. Validation and Supervision: Fang Peng, Ning Li, Run Yao. All authors have read and approved the final version of the manuscript.

Funding

The authors sincerely acknowledge the financial support from the National Natural Science Foundation of China (82270633) and the Natural Science Foundation of Hunan Province (2023JJ30932).

Data availability

No datasets were generated or analysed during the current study.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Abbreviations

ALD Autoimmune liver disease

AIH Autoimmune hepatitis

CARD Caspase activation and recruitment domain

cAMP Cyclic AMP

cGAMP Cyclic GMP-AMP

cGAS Cyclic GMP-AMP synthase

DILI Drug-induced liver injury

ER Endoplasmic reticulum

FUS Fused in sarcoma

G3BP1 GAP SH3 binding protein 1

HBV Hepatitis B virus

HBx Hepatitis B virus X protein

HCC Hepatocellular carcinoma

HSCs Hepatic stellate cells

HCV Hepatitis C virus

IDR Intrinsically disordered region

IFN Interferon

IRF3 Interferon regulatory factor 3

IRI Ischemia-reperfusion injury

IL Interleukins

KC Kupffer cells

LCD Low complexity domain

LLPS Liquid-liquid phase separation

MAVS Mitochondrial antiviral signaling protein

NAFL Non-alcoholic fatty liver

NAFLD Non-alcoholic fatty liver disease

NASH Non-alcoholic steatohepatitis

NLRs NOD-like receptors

NK Natural killer

PKA Protein kinase A

PRRs Pattern recognition receptors

PTM Post-translational modification

RIG-I Retinoic acid-inducible gene I protein

ROS Reactive oxygen species

SG Stress granule

STING Stimulator of interferon genes

TBK1 TANK-binding kinase 1

TNFα Tumor necrosis factor-α

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Banani SF Biomolecular condensates: organizers of cellular biochemistry Nat Rev Mol Cell Biol 2017 18 5 285 98 10.1038/nrm.2017.7 28225081
Banani SF, et al. Biomolecular condensates: organizers of cellular biochemistry. Nat Rev Mol Cell Biol. 2017;18(5):285–98.28225081 10.1038/nrm.2017.7
2. Wang B Liquid-liquid phase separation in human health and diseases Signal Transduct Target Ther 2021 6 1 290 10.1038/s41392-021-00678-1 34334791
Wang B, et al. Liquid-liquid phase separation in human health and diseases. Signal Transduct Target Ther. 2021;6(1):290.34334791 10.1038/s41392-021-00678-1
3. Niu X Biomolecular condensates: formation mechanisms, biological functions, and therapeutic targets MedComm 2020 2023 42 pe223
Niu X, et al. Biomolecular condensates: formation mechanisms, biological functions, and therapeutic targets. MedComm. 2020;2023(42):pe223.
4. Alberti S Dormann D Liquid-liquid phase separation in Disease Annu Rev Genet 2019 53 171 94 10.1146/annurev-genet-112618-043527 31430179
Alberti S, Dormann D. Liquid-liquid phase separation in Disease. Annu Rev Genet. 2019;53:171–94.31430179 10.1146/annurev-genet-112618-043527
5. Liu-Yesucevitz L Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue PLoS ONE 2010 5 10 e13250 10.1371/journal.pone.0013250 20948999
Liu-Yesucevitz L, et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS ONE. 2010;5(10):e13250.20948999 10.1371/journal.pone.0013250
6. Zhang L Phase separation in kidney diseases: autosomal Dominant polycystic kidney Disease and Beyond Kidney Dis (Basel) 2023 9 4 229 38 10.1159/000530250 37899998
Zhang L, et al. Phase separation in kidney diseases: autosomal Dominant polycystic kidney Disease and Beyond. Kidney Dis (Basel). 2023;9(4):229–38.37899998 10.1159/000530250
7. Wang X Development of cyclopeptide inhibitors of cGAS targeting protein-DNA interaction and phase separation Nat Commun 2023 14 1 6132 10.1038/s41467-023-41892-5 37783727
Wang X, et al. Development of cyclopeptide inhibitors of cGAS targeting protein-DNA interaction and phase separation. Nat Commun. 2023;14(1):6132.37783727 10.1038/s41467-023-41892-5
8. Liu D, Yang J, Cristea IM. Liquid-liquid phase separation in innate immunity. Trends Immunol; 2024.
9. Neshat SY et al. Liver Disease: induction, progression, immunological mechanisms, and therapeutic interventions. Int J Mol Sci, 2021. 22(13).
10. Li J Macrophage mitochondrial fission improves cancer cell phagocytosis induced by therapeutic antibodies and is impaired by glutamine competition Nat Cancer 2022 3 4 453 70 10.1038/s43018-022-00354-5 35484420
Li J, et al. Macrophage mitochondrial fission improves cancer cell phagocytosis induced by therapeutic antibodies and is impaired by glutamine competition. Nat Cancer. 2022;3(4):453–70.35484420 10.1038/s43018-022-00354-5
11. Chen H Self-programmed dynamics of T cell receptor condensation Proc Natl Acad Sci U S A 2023 120 28 e2217301120 10.1073/pnas.2217301120 37399423
Chen H, et al. Self-programmed dynamics of T cell receptor condensation. Proc Natl Acad Sci U S A. 2023;120(28):e2217301120.37399423 10.1073/pnas.2217301120
12. Chen B cGAS-STING Signaling Pathway and Liver Disease: from Basic Research to Clinical Practice Front Pharmacol 2021 12 719644 10.3389/fphar.2021.719644 34483930
Chen B, et al. cGAS-STING Signaling Pathway and Liver Disease: from Basic Research to Clinical Practice. Front Pharmacol. 2021;12:719644.34483930 10.3389/fphar.2021.719644
13. Hopfner KP Hornung V Molecular mechanisms and cellular functions of cGAS-STING signalling Nat Rev Mol Cell Biol 2020 21 9 501 21 10.1038/s41580-020-0244-x 32424334
Hopfner KP, Hornung V. Molecular mechanisms and cellular functions of cGAS-STING signalling. Nat Rev Mol Cell Biol. 2020;21(9):501–21.32424334 10.1038/s41580-020-0244-x
14. Brangwynne CP Germline P granules are liquid droplets that localize by controlled dissolution/condensation Science 2009 324 5935 1729 32 10.1126/science.1172046 19460965
Brangwynne CP, et al. Germline P granules are liquid droplets that localize by controlled dissolution/condensation. Science. 2009;324(5935):1729–32.19460965 10.1126/science.1172046
15. Li P Phase transitions in the assembly of multivalent signalling proteins Nature 2012 483 7389 336 40 10.1038/nature10879 22398450
Li P, et al. Phase transitions in the assembly of multivalent signalling proteins. Nature. 2012;483(7389):336–40.22398450 10.1038/nature10879
16. Kato M Redox State Controls phase separation of the yeast Ataxin-2 protein via reversible oxidation of its methionine-rich low-complexity domain Cell 2019 177 3 711 e7218 10.1016/j.cell.2019.02.044 30982603
Kato M, et al. Redox State Controls phase separation of the yeast Ataxin-2 protein via reversible oxidation of its methionine-rich low-complexity domain. Cell. 2019;177(3):711–e7218.30982603 10.1016/j.cell.2019.02.044
17. Dundr M Misteli T Functional architecture in the cell nucleus Biochem J 2001 356 Pt 2 297 310 10.1042/bj3560297 11368755
Dundr M, Misteli T. Functional architecture in the cell nucleus. Biochem J. 2001;356(Pt 2):297–310.11368755 10.1042/bj3560297
18. Brangwynne CP Mitchison TJ Hyman AA Active liquid-like behavior of nucleoli determines their size and shape in Xenopus laevis oocytes Proc Natl Acad Sci U S A 2011 108 11 4334 9 10.1073/pnas.1017150108 21368180
Brangwynne CP, Mitchison TJ, Hyman AA. Active liquid-like behavior of nucleoli determines their size and shape in Xenopus laevis oocytes. Proc Natl Acad Sci U S A. 2011;108(11):4334–9.21368180 10.1073/pnas.1017150108
19. Lafontaine DLJ The nucleolus as a multiphase liquid condensate Nat Rev Mol Cell Biol 2021 22 3 165 82 10.1038/s41580-020-0272-6 32873929
Lafontaine DLJ, et al. The nucleolus as a multiphase liquid condensate. Nat Rev Mol Cell Biol. 2021;22(3):165–82.32873929 10.1038/s41580-020-0272-6
20. Alston JJ Soranno A Condensation goes viral: a polymer physics perspective J Mol Biol 2023 435 16 167988 10.1016/j.jmb.2023.167988 36709795
Alston JJ, Soranno A. Condensation goes viral: a polymer physics perspective. J Mol Biol. 2023;435(16):167988.36709795 10.1016/j.jmb.2023.167988
21. Hyman AA Weber CA Jülicher F Liquid-liquid phase separation in biology Annu Rev Cell Dev Biol 2014 30 39 58 10.1146/annurev-cellbio-100913-013325 25288112
Hyman AA, Weber CA, Jülicher F. Liquid-liquid phase separation in biology. Annu Rev Cell Dev Biol. 2014;30:39–58.25288112 10.1146/annurev-cellbio-100913-013325
22. Gomes E Shorter J The molecular language of membraneless organelles J Biol Chem 2019 294 18 7115 27 10.1074/jbc.TM118.001192 30045872
Gomes E, Shorter J. The molecular language of membraneless organelles. J Biol Chem. 2019;294(18):7115–27.30045872 10.1074/jbc.TM118.001192
23. Vernon RM et al. Pi-Pi contacts are an overlooked protein feature relevant to phase separation. Elife, 2018. 7.
24. Nott TJ Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles Mol Cell 2015 57 5 936 47 10.1016/j.molcel.2015.01.013 25747659
Nott TJ, et al. Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles. Mol Cell. 2015;57(5):936–47.25747659 10.1016/j.molcel.2015.01.013
25. Boeynaems S Phase separation of C9orf72 dipeptide repeats perturbs stress Granule Dynamics Mol Cell 2017 65 6 1044 e10555 10.1016/j.molcel.2017.02.013 28306503
Boeynaems S, et al. Phase separation of C9orf72 dipeptide repeats perturbs stress Granule Dynamics. Mol Cell. 2017;65(6):1044–e10555.28306503 10.1016/j.molcel.2017.02.013
26. Murray DT Structure of FUS protein fibrils and its relevance to self-assembly and phase separation of low-complexity domains Cell 2017 171 3 615 e62716 10.1016/j.cell.2017.08.048 28942918
Murray DT, et al. Structure of FUS protein fibrils and its relevance to self-assembly and phase separation of low-complexity domains. Cell. 2017;171(3):615–e62716.28942918 10.1016/j.cell.2017.08.048
27. Lubkowska A et al. Role of heat shock proteins (HSP70 and HSP90) in viral infection. Int J Mol Sci, 2021. 22(17).
28. Peng L Li EM Xu LY From start to end: phase separation and transcriptional regulation Biochim Biophys Acta Gene Regul Mech 2020 1863 12 194641 10.1016/j.bbagrm.2020.194641 33017669
Peng L, Li EM, Xu LY. From start to end: phase separation and transcriptional regulation. Biochim Biophys Acta Gene Regul Mech. 2020;1863(12):194641.33017669 10.1016/j.bbagrm.2020.194641
29. Zhao YG Zhang H Phase separation in membrane Biology: the interplay between membrane-bound organelles and Membraneless Condensates Dev Cell 2020 55 1 30 44 10.1016/j.devcel.2020.06.033 32726575
Zhao YG, Zhang H. Phase separation in membrane Biology: the interplay between membrane-bound organelles and Membraneless Condensates. Dev Cell. 2020;55(1):30–44.32726575 10.1016/j.devcel.2020.06.033
30. Kwon I Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains Cell 2013 155 5 1049 60 10.1016/j.cell.2013.10.033 24267890
Kwon I, et al. Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains. Cell. 2013;155(5):1049–60.24267890 10.1016/j.cell.2013.10.033
31. Sang D Condensed-phase signaling can expand kinase specificity and respond to macromolecular crowding Mol Cell 2022 82 19 3693 e371110 10.1016/j.molcel.2022.08.016 36108633
Sang D, et al. Condensed-phase signaling can expand kinase specificity and respond to macromolecular crowding. Mol Cell. 2022;82(19):3693–e371110.36108633 10.1016/j.molcel.2022.08.016
32. Jiang N Acetylation in pathogenesis: revealing emerging mechanisms and therapeutic prospects Biomed Pharmacother 2023 167 115519 10.1016/j.biopha.2023.115519 37729729
Jiang N, et al. Acetylation in pathogenesis: revealing emerging mechanisms and therapeutic prospects. Biomed Pharmacother. 2023;167:115519.37729729 10.1016/j.biopha.2023.115519
33. Liu Y Crosstalk between protein post-translational modifications and phase separation Cell Commun Signal 2024 22 1 110 10.1186/s12964-023-01380-1 38347544
Liu Y, et al. Crosstalk between protein post-translational modifications and phase separation. Cell Commun Signal. 2024;22(1):110.38347544 10.1186/s12964-023-01380-1
34. Protter DSW Parker R Principles and properties of stress granules Trends Cell Biol 2016 26 9 668 79 10.1016/j.tcb.2016.05.004 27289443
Protter DSW, Parker R. Principles and properties of stress granules. Trends Cell Biol. 2016;26(9):668–79.27289443 10.1016/j.tcb.2016.05.004
35. Sidibé H Dubinski A Vande C Velde The multi-functional RNA-binding protein G3BP1 and its potential implication in neurodegenerative disease J Neurochem 2021 157 4 944 62 10.1111/jnc.15280 33349931
Sidibé H, Dubinski A, Vande C, Velde. The multi-functional RNA-binding protein G3BP1 and its potential implication in neurodegenerative disease. J Neurochem. 2021;157(4):944–62.33349931 10.1111/jnc.15280
36. Jin G G3BP2: structure and function Pharmacol Res 2022 186 106548 10.1016/j.phrs.2022.106548 36336216
Jin G, et al. G3BP2: structure and function. Pharmacol Res. 2022;186:106548.36336216 10.1016/j.phrs.2022.106548
37. Kedersha N G3BP-Caprin1-USP10 complexes mediate stress granule condensation and associate with 40S subunits J Cell Biol 2016 212 7 845 60 10.1083/jcb.201508028 27022092
Kedersha N, et al. G3BP-Caprin1-USP10 complexes mediate stress granule condensation and associate with 40S subunits. J Cell Biol. 2016;212(7):845–60.27022092 10.1083/jcb.201508028
38. Shakya A Liquid-liquid phase separation of Histone Proteins in cells: role in chromatin Organization Biophys J 2020 118 3 753 64 10.1016/j.bpj.2019.12.022 31952807
Shakya A, et al. Liquid-liquid phase separation of Histone Proteins in cells: role in chromatin Organization. Biophys J. 2020;118(3):753–64.31952807 10.1016/j.bpj.2019.12.022
39. Li P et al. High-throughput and proteome-wide discovery of endogenous biomolecular condensates. Nat Chem, 2024.
40. Li W Jiang H Nuclear protein condensates and their properties in Regulation of Gene expression J Mol Biol 2022 434 1 167151 10.1016/j.jmb.2021.167151 34271007
Li W, Jiang H. Nuclear protein condensates and their properties in Regulation of Gene expression. J Mol Biol. 2022;434(1):167151.34271007 10.1016/j.jmb.2021.167151
41. Shrinivas K Enhancer features that drive formation of Transcriptional Condensates Mol Cell 2019 75 3 549 e5617 10.1016/j.molcel.2019.07.009 31398323
Shrinivas K, et al. Enhancer features that drive formation of Transcriptional Condensates. Mol Cell. 2019;75(3):549–e5617.31398323 10.1016/j.molcel.2019.07.009
42. Hnisz D A phase separation model for Transcriptional Control Cell 2017 169 1 13 23 10.1016/j.cell.2017.02.007 28340338
Hnisz D, et al. A phase separation model for Transcriptional Control. Cell. 2017;169(1):13–23.28340338 10.1016/j.cell.2017.02.007
43. Yokoshi M Direct binding of Ataxin-2 to distinct elements in 3’ UTRs promotes mRNA stability and protein expression Mol Cell 2014 55 2 186 98 10.1016/j.molcel.2014.05.022 24954906
Yokoshi M, et al. Direct binding of Ataxin-2 to distinct elements in 3’ UTRs promotes mRNA stability and protein expression. Mol Cell. 2014;55(2):186–98.24954906 10.1016/j.molcel.2014.05.022
44. Zhuang Y Circadian clocks are modulated by compartmentalized oscillating translation Cell 2023 186 15 3245 e326023 10.1016/j.cell.2023.05.045 37369203
Zhuang Y, et al. Circadian clocks are modulated by compartmentalized oscillating translation. Cell. 2023;186(15):3245–e326023.37369203 10.1016/j.cell.2023.05.045
45. Bhatter N Dmitriev SE Ivanov P Cell death or survival: insights into the role of mRNA translational control Semin Cell Dev Biol 2024 154 Pt B 138 54 10.1016/j.semcdb.2023.06.006 37357122
Bhatter N, Dmitriev SE, Ivanov P. Cell death or survival: insights into the role of mRNA translational control. Semin Cell Dev Biol. 2024;154(Pt B):138–54.37357122 10.1016/j.semcdb.2023.06.006
46. Eiermann N et al. Dance with the Devil: stress granules and signaling in antiviral responses. Viruses, 2020. 12(9).
47. Li J Protein phase separation and its role in chromatin organization and diseases Biomed Pharmacother 2021 138 111520 10.1016/j.biopha.2021.111520 33765580
Li J, et al. Protein phase separation and its role in chromatin organization and diseases. Biomed Pharmacother. 2021;138:111520.33765580 10.1016/j.biopha.2021.111520
48. Strom AR Phase separation drives heterochromatin domain formation Nature 2017 547 7662 241 5 10.1038/nature22989 28636597
Strom AR, et al. Phase separation drives heterochromatin domain formation. Nature. 2017;547(7662):241–5.28636597 10.1038/nature22989
49. Leicher R Single-stranded nucleic acid binding and coacervation by linker histone H1 Nat Struct Mol Biol 2022 29 5 463 71 10.1038/s41594-022-00760-4 35484234
Leicher R, et al. Single-stranded nucleic acid binding and coacervation by linker histone H1. Nat Struct Mol Biol. 2022;29(5):463–71.35484234 10.1038/s41594-022-00760-4
50. Wang L Rett syndrome-causing mutations compromise MeCP2-mediated liquid-liquid phase separation of chromatin Cell Res 2020 30 5 393 407 10.1038/s41422-020-0288-7 32111972
Wang L, et al. Rett syndrome-causing mutations compromise MeCP2-mediated liquid-liquid phase separation of chromatin. Cell Res. 2020;30(5):393–407.32111972 10.1038/s41422-020-0288-7
51. Zhang H MeCP2-induced heterochromatin organization is driven by oligomerization-based liquid-liquid phase separation and restricted by DNA methylation Nucleus 2022 13 1 1 34 10.1080/19491034.2021.2024691 35156529
Zhang H, et al. MeCP2-induced heterochromatin organization is driven by oligomerization-based liquid-liquid phase separation and restricted by DNA methylation. Nucleus. 2022;13(1):1–34.35156529 10.1080/19491034.2021.2024691
52. Lin CC Receptor tyrosine kinases regulate signal transduction through a liquid-liquid phase separated state Mol Cell 2022 82 6 1089 e110612 10.1016/j.molcel.2022.02.005 35231400
Lin CC, et al. Receptor tyrosine kinases regulate signal transduction through a liquid-liquid phase separated state. Mol Cell. 2022;82(6):1089–e110612.35231400 10.1016/j.molcel.2022.02.005
53. Ladbury JE Lin CC Suen KM Phase separation enhances probability of receptor signalling and drug targeting Trends Biochem Sci 2023 48 5 428 36 10.1016/j.tibs.2023.01.005 36759237
Ladbury JE, Lin CC, Suen KM. Phase separation enhances probability of receptor signalling and drug targeting. Trends Biochem Sci. 2023;48(5):428–36.36759237 10.1016/j.tibs.2023.01.005
54. Qin M et al. LATS2 condensates organize signalosomes for Hippo pathway signal transduction. Nat Chem Biol, 2024.
55. Zeng M Phase transition in postsynaptic densities underlies formation of synaptic complexes and synaptic plasticity Cell 2016 166 5 1163 e117512 10.1016/j.cell.2016.07.008 27565345
Zeng M, et al. Phase transition in postsynaptic densities underlies formation of synaptic complexes and synaptic plasticity. Cell. 2016;166(5):1163–e117512.27565345 10.1016/j.cell.2016.07.008
56. Lv P O-GlcNAcylation modulates liquid-liquid phase separation of SynGAP/PSD-95 Nat Chem 2022 14 7 831 40 10.1038/s41557-022-00946-9 35637289
Lv P, et al. O-GlcNAcylation modulates liquid-liquid phase separation of SynGAP/PSD-95. Nat Chem. 2022;14(7):831–40.35637289 10.1038/s41557-022-00946-9
57. Liu C Phase separation in cGAS-STING signaling: cytosolic DNA sensing and Regulatory functions ChemBioChem 2023 24 10 e202300147 10.1002/cbic.202300147 37041126
Liu C, et al. Phase separation in cGAS-STING signaling: cytosolic DNA sensing and Regulatory functions. ChemBioChem. 2023;24(10):e202300147.37041126 10.1002/cbic.202300147
58. Srikanth S The ca(2+) sensor STIM1 regulates the type I interferon response by retaining the signaling adaptor STING at the endoplasmic reticulum Nat Immunol 2019 20 2 152 62 10.1038/s41590-018-0287-8 30643259
Srikanth S, et al. The ca(2+) sensor STIM1 regulates the type I interferon response by retaining the signaling adaptor STING at the endoplasmic reticulum. Nat Immunol. 2019;20(2):152–62.30643259 10.1038/s41590-018-0287-8
59. Liu S Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation Science 2015 347 6227 aaa2630 10.1126/science.aaa2630 25636800
Liu S, et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science. 2015;347(6227):aaa2630.25636800 10.1126/science.aaa2630
60. Zhang C Structural basis of STING binding with and phosphorylation by TBK1 Nature 2019 567 7748 394 8 10.1038/s41586-019-1000-2 30842653
Zhang C, et al. Structural basis of STING binding with and phosphorylation by TBK1. Nature. 2019;567(7748):394–8.30842653 10.1038/s41586-019-1000-2
61. Zhou S Engineering cGAS-agonistic oligonucleotides as therapeutics for cancer immunotherapy Mol Ther Nucleic Acids 2024 35 1 102126 10.1016/j.omtn.2024.102126 38352859
Zhou S, et al. Engineering cGAS-agonistic oligonucleotides as therapeutics for cancer immunotherapy. Mol Ther Nucleic Acids. 2024;35(1):102126.38352859 10.1016/j.omtn.2024.102126
62. Yu X The STING phase-separator suppresses innate immune signalling Nat Cell Biol 2021 23 4 330 40 10.1038/s41556-021-00659-0 33833429
Yu X, et al. The STING phase-separator suppresses innate immune signalling. Nat Cell Biol. 2021;23(4):330–40.33833429 10.1038/s41556-021-00659-0
63. Hou J Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma Cancer Cell 2014 25 1 49 63 10.1016/j.ccr.2013.11.011 24360797
Hou J, et al. Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma. Cancer Cell. 2014;25(1):49–63.24360797 10.1016/j.ccr.2013.11.011
64. Seth RB Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3 Cell 2005 122 5 669 82 10.1016/j.cell.2005.08.012 16125763
Seth RB, et al. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 2005;122(5):669–82.16125763 10.1016/j.cell.2005.08.012
65. Zeng W Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity Cell 2010 141 2 315 30 10.1016/j.cell.2010.03.029 20403326
Zeng W, et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell. 2010;141(2):315–30.20403326 10.1016/j.cell.2010.03.029
66. Malik A Kanneganti TD Inflammasome activation and assembly at a glance J Cell Sci 2017 130 23 3955 63 10.1242/jcs.207365 29196474
Malik A, Kanneganti TD. Inflammasome activation and assembly at a glance. J Cell Sci. 2017;130(23):3955–63.29196474 10.1242/jcs.207365
67. Luan J Ju D Inflammasome: a double-edged Sword in Liver diseases Front Immunol 2018 9 2201 10.3389/fimmu.2018.02201 30319645
Luan J, Ju D. Inflammasome: a double-edged Sword in Liver diseases. Front Immunol. 2018;9:2201.30319645 10.3389/fimmu.2018.02201
68. Mathur A Hayward JA Man SM Molecular mechanisms of inflammasome signaling J Leukoc Biol 2018 103 2 233 57 10.1189/jlb.3MR0617-250R 28855232
Mathur A, Hayward JA, Man SM. Molecular mechanisms of inflammasome signaling. J Leukoc Biol. 2018;103(2):233–57.28855232 10.1189/jlb.3MR0617-250R
69. Shen C Phase separation drives RNA virus-induced activation of the NLRP6 inflammasome Cell 2021 184 23 5759 e577420 10.1016/j.cell.2021.09.032 34678144
Shen C, et al. Phase separation drives RNA virus-induced activation of the NLRP6 inflammasome. Cell. 2021;184(23):5759–e577420.34678144 10.1016/j.cell.2021.09.032
70. Deretic V Levine B Autophagy balances inflammation in innate immunity Autophagy 2018 14 2 243 51 10.1080/15548627.2017.1402992 29165043
Deretic V, Levine B. Autophagy balances inflammation in innate immunity. Autophagy. 2018;14(2):243–51.29165043 10.1080/15548627.2017.1402992
71. Deretic V Autophagy in inflammation, infection, and immunometabolism Immunity 2021 54 3 437 53 10.1016/j.immuni.2021.01.018 33691134
Deretic V. Autophagy in inflammation, infection, and immunometabolism. Immunity. 2021;54(3):437–53.33691134 10.1016/j.immuni.2021.01.018
72. Fujioka Y Phase separation organizes the site of autophagosome formation Nature 2020 578 7794 301 5 10.1038/s41586-020-1977-6 32025038
Fujioka Y, et al. Phase separation organizes the site of autophagosome formation. Nature. 2020;578(7794):301–5.32025038 10.1038/s41586-020-1977-6
73. Agudo-Canalejo J Wetting regulates autophagy of phase-separated compartments and the cytosol Nature 2021 591 7848 142 6 10.1038/s41586-020-2992-3 33473217
Agudo-Canalejo J, et al. Wetting regulates autophagy of phase-separated compartments and the cytosol. Nature. 2021;591(7848):142–6.33473217 10.1038/s41586-020-2992-3
74. Sun D Polyubiquitin chain-induced p62 phase separation drives autophagic cargo segregation Cell Res 2018 28 4 405 15 10.1038/s41422-018-0017-7 29507397
Sun D, et al. Polyubiquitin chain-induced p62 phase separation drives autophagic cargo segregation. Cell Res. 2018;28(4):405–15.29507397 10.1038/s41422-018-0017-7
75. Bjørkøy G p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death J Cell Biol 2005 171 4 603 14 10.1083/jcb.200507002 16286508
Bjørkøy G, et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol. 2005;171(4):603–14.16286508 10.1083/jcb.200507002
76. Glick D Barth S Macleod KF Autophagy: cellular and molecular mechanisms J Pathol 2010 221 1 3 12 10.1002/path.2697 20225336
Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010;221(1):3–12.20225336 10.1002/path.2697
77. Filali-Mouncef Y The ménage à Trois of autophagy, lipid droplets and liver disease Autophagy 2022 18 1 50 72 10.1080/15548627.2021.1895658 33794741
Filali-Mouncef Y, et al. The ménage à Trois of autophagy, lipid droplets and liver disease. Autophagy. 2022;18(1):50–72.33794741 10.1080/15548627.2021.1895658
78. Xu D The cGAS-STING pathway: Novel perspectives in Liver diseases Front Immunol 2021 12 682736 10.3389/fimmu.2021.682736 33995425
Xu D, et al. The cGAS-STING pathway: Novel perspectives in Liver diseases. Front Immunol. 2021;12:682736.33995425 10.3389/fimmu.2021.682736
79. Guo F et al. Activation of Stimulator of Interferon genes in Hepatocytes suppresses the replication of Hepatitis B Virus. Antimicrob Agents Chemother, 2017. 61(10).
80. Li M Kupffer cells support Hepatitis B virus-mediated CD8 + T cell exhaustion via Hepatitis B Core Antigen-TLR2 interactions in mice J Immunol 2015 195 7 3100 9 10.4049/jimmunol.1500839 26304988
Li M, et al. Kupffer cells support Hepatitis B virus-mediated CD8 + T cell exhaustion via Hepatitis B Core Antigen-TLR2 interactions in mice. J Immunol. 2015;195(7):3100–9.26304988 10.4049/jimmunol.1500839
81. Li Y STING signaling activation inhibits HBV replication and attenuates the severity of liver injury and HBV-induced fibrosis Cell Mol Immunol 2022 19 1 92 107 10.1038/s41423-021-00801-w 34811496
Li Y, et al. STING signaling activation inhibits HBV replication and attenuates the severity of liver injury and HBV-induced fibrosis. Cell Mol Immunol. 2022;19(1):92–107.34811496 10.1038/s41423-021-00801-w
82. Ding Q Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity J Hepatol 2013 59 1 52 8 10.1016/j.jhep.2013.03.019 23542348
Ding Q, et al. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity. J Hepatol. 2013;59(1):52–8.23542348 10.1016/j.jhep.2013.03.019
83. He J Inhibition of hepatitis B virus replication by activation of the cGAS-STING pathway J Gen Virol 2016 97 12 3368 78 10.1099/jgv.0.000647 27902332
He J, et al. Inhibition of hepatitis B virus replication by activation of the cGAS-STING pathway. J Gen Virol. 2016;97(12):3368–78.27902332 10.1099/jgv.0.000647
84. Nassal M HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B Gut 2015 64 12 1972 84 10.1136/gutjnl-2015-309809 26048673
Nassal M. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut. 2015;64(12):1972–84.26048673 10.1136/gutjnl-2015-309809
85. Lee S Suppression of hepatitis B virus through therapeutic activation of RIG-I and IRF3 signaling in hepatocytes iScience 2021 24 1 101969 10.1016/j.isci.2020.101969 33458618
Lee S, et al. Suppression of hepatitis B virus through therapeutic activation of RIG-I and IRF3 signaling in hepatocytes. iScience. 2021;24(1):101969.33458618 10.1016/j.isci.2020.101969
86. Mu Y et al. Codelivery of HBx-siRNA and plasmid encoding IL-12 for inhibition of Hepatitis B Virus and Reactivation of antiviral immunity. Pharmaceutics, 2022. 14(7).
87. Giraud G G-quadruplexes control hepatitis B virus replication by promoting cccDNA transcription and phase separation in hepatocytes Nucleic Acids Res 2024 52 5 2290 305 10.1093/nar/gkad1200 38113270
Giraud G, et al. G-quadruplexes control hepatitis B virus replication by promoting cccDNA transcription and phase separation in hepatocytes. Nucleic Acids Res. 2024;52(5):2290–305.38113270 10.1093/nar/gkad1200
88. Vilasco M The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected livers Hepatology 2006 44 6 1635 47 10.1002/hep.21432 17133498
Vilasco M, et al. The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected livers. Hepatology. 2006;44(6):1635–47.17133498 10.1002/hep.21432
89. Lowey B et al. Hepatitis C virus infection induces hepatic expression of NF-κB-Inducing kinase and Lipogenesis by downregulating miR-122. mBio, 2019. 10(4).
90. Sir D Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response Hepatology 2008 48 4 1054 61 10.1002/hep.22464 18688877
Sir D, et al. Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response. Hepatology. 2008;48(4):1054–61.18688877 10.1002/hep.22464
91. Sir D Ann DK Ou JH Autophagy by hepatitis B virus and for hepatitis B virus Autophagy 2010 6 4 548 9 10.4161/auto.6.4.11669 20305390
Sir D, Ann DK, Ou JH. Autophagy by hepatitis B virus and for hepatitis B virus. Autophagy. 2010;6(4):548–9.20305390 10.4161/auto.6.4.11669
92. Khan M Imam H Siddiqui A Subversion of cellular autophagy during virus infection: insights from hepatitis B and hepatitis C viruses Liver Res 2018 2 3 146 56 10.1016/j.livres.2018.09.002 31803515
Khan M, Imam H, Siddiqui A. Subversion of cellular autophagy during virus infection: insights from hepatitis B and hepatitis C viruses. Liver Res. 2018;2(3):146–56.31803515 10.1016/j.livres.2018.09.002
93. Liu B Hepatitis B virus X protein inhibits autophagic degradation by impairing lysosomal maturation Autophagy 2014 10 3 416 30 10.4161/auto.27286 24401568
Liu B, et al. Hepatitis B virus X protein inhibits autophagic degradation by impairing lysosomal maturation. Autophagy. 2014;10(3):416–30.24401568 10.4161/auto.27286
94. Petrasek J STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease Proc Natl Acad Sci U S A 2013 110 41 16544 9 10.1073/pnas.1308331110 24052526
Petrasek J, et al. STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. Proc Natl Acad Sci U S A. 2013;110(41):16544–9.24052526 10.1073/pnas.1308331110
95. Luo T Hepatocyte DDX3X protects against drug-induced acute liver injury via controlling stress granule formation and oxidative stress Cell Death Dis 2023 14 7 400 10.1038/s41419-023-05913-x 37407573
Luo T, et al. Hepatocyte DDX3X protects against drug-induced acute liver injury via controlling stress granule formation and oxidative stress. Cell Death Dis. 2023;14(7):400.37407573 10.1038/s41419-023-05913-x
96. Bartolini D Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma Transl Res 2018 193 54 71 10.1016/j.trsl.2017.11.007 29274776
Bartolini D, et al. Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma. Transl Res. 2018;193:54–71.29274776 10.1016/j.trsl.2017.11.007
97. Liu Q Glycogen accumulation and phase separation drives liver tumor initiation Cell 2021 184 22 5559 e557619 10.1016/j.cell.2021.10.001 34678143
Liu Q, et al. Glycogen accumulation and phase separation drives liver tumor initiation. Cell. 2021;184(22):5559–e557619.34678143 10.1016/j.cell.2021.10.001
98. Wang X STING expression in monocyte-derived macrophages is associated with the progression of liver inflammation and fibrosis in patients with nonalcoholic fatty liver disease Lab Invest 2020 100 4 542 52 10.1038/s41374-019-0342-6 31745210
Wang X, et al. STING expression in monocyte-derived macrophages is associated with the progression of liver inflammation and fibrosis in patients with nonalcoholic fatty liver disease. Lab Invest. 2020;100(4):542–52.31745210 10.1038/s41374-019-0342-6
99. Su W TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling JHEP Rep 2023 5 5 100695 10.1016/j.jhepr.2023.100695 36968217
Su W, et al. TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling. JHEP Rep. 2023;5(5):100695.36968217 10.1016/j.jhepr.2023.100695
100. Liu J The Macrophage-Associated LncRNA MALR facilitates ILF3 liquid-liquid phase separation to promote HIF1α signaling in Esophageal Cancer Cancer Res 2023 83 9 1476 89 10.1158/0008-5472.CAN-22-1922 36264156
Liu J, et al. The Macrophage-Associated LncRNA MALR facilitates ILF3 liquid-liquid phase separation to promote HIF1α signaling in Esophageal Cancer. Cancer Res. 2023;83(9):1476–89.36264156 10.1158/0008-5472.CAN-22-1922
101. Luo S Activation of cGAS-STING signaling pathway promotes liver fibrosis and hepatic sinusoidal microthrombosis Int Immunopharmacol 2023 125Pt B p111132 10.1016/j.intimp.2023.111132
Luo S, et al. Activation of cGAS-STING signaling pathway promotes liver fibrosis and hepatic sinusoidal microthrombosis. Int Immunopharmacol. 2023;125Pt B:p111132.10.1016/j.intimp.2023.111132
102. Wang L Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and ameliorates organ fibrosis Eur J Pharmacol 2022 932 175241 10.1016/j.ejphar.2022.175241 36058291
Wang L, et al. Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and ameliorates organ fibrosis. Eur J Pharmacol. 2022;932:175241.36058291 10.1016/j.ejphar.2022.175241
103. Fernández-Martín JC et al. Gal3 plays a deleterious role in a mouse model of Endotoxemia. Int J Mol Sci, 2022. 23(3).
104. Dong K Mixed micelles loaded with hesperidin protect against acetaminophen induced acute liver injury by inhibiting the mtDNA-cGAS-STING pathway Colloids Surf B Biointerfaces 2023 233 113656 10.1016/j.colsurfb.2023.113656 37984191
Dong K, et al. Mixed micelles loaded with hesperidin protect against acetaminophen induced acute liver injury by inhibiting the mtDNA-cGAS-STING pathway. Colloids Surf B Biointerfaces. 2023;233:113656.37984191 10.1016/j.colsurfb.2023.113656
105. Saito M Acetylation of intrinsically disordered regions regulates phase separation Nat Chem Biol 2019 15 1 51 61 10.1038/s41589-018-0180-7 30531905
Saito M, et al. Acetylation of intrinsically disordered regions regulates phase separation. Nat Chem Biol. 2019;15(1):51–61.30531905 10.1038/s41589-018-0180-7
106. Li Y Chlorpromazine protects against acetaminophen-induced liver injury in mice by modulating autophagy and c-Jun N-terminal kinase activation Liver Res 2019 3 1 65 74 10.1016/j.livres.2019.01.004 31815033
Li Y, et al. Chlorpromazine protects against acetaminophen-induced liver injury in mice by modulating autophagy and c-Jun N-terminal kinase activation. Liver Res. 2019;3(1):65–74.31815033 10.1016/j.livres.2019.01.004
107. Mo R Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injury Theranostics 2018 8 15 4170 80 10.7150/thno.25798 30128045
Mo R, et al. Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injury. Theranostics. 2018;8(15):4170–80.30128045 10.7150/thno.25798
108. Powell EE Wong VW Rinella M Non-alcoholic fatty liver disease Lancet 2021 397 10290 2212 24 10.1016/S0140-6736(20)32511-3 33894145
Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212–24.33894145 10.1016/S0140-6736(20)32511-3
109. Mao Y STING-IRF3 triggers endothelial inflammation in response to free fatty acid-Induced mitochondrial damage in Diet-Induced obesity Arterioscler Thromb Vasc Biol 2017 37 5 920 9 10.1161/ATVBAHA.117.309017 28302626
Mao Y, et al. STING-IRF3 triggers endothelial inflammation in response to free fatty acid-Induced mitochondrial damage in Diet-Induced obesity. Arterioscler Thromb Vasc Biol. 2017;37(5):920–9.28302626 10.1161/ATVBAHA.117.309017
110. Yu Y STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis J Clin Invest 2019 129 2 546 55 10.1172/JCI121842 30561388
Yu Y, et al. STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis. J Clin Invest. 2019;129(2):546–55.30561388 10.1172/JCI121842
111. Luo X et al. Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice. Gastroenterology, 2018. 155(6): p. 1971–1984.e4.
112. Donne R Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD Dev Cell 2022 57 14 1728 e17416 10.1016/j.devcel.2022.06.003 35768000
Donne R, et al. Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD. Dev Cell. 2022;57(14):1728–e17416.35768000 10.1016/j.devcel.2022.06.003
113. Parthasarathy G Revelo X Malhi H Pathogenesis of nonalcoholic steatohepatitis: an overview Hepatol Commun 2020 4 4 478 92 10.1002/hep4.1479 32258944
Parthasarathy G, Revelo X, Malhi H. Pathogenesis of nonalcoholic steatohepatitis: an overview. Hepatol Commun. 2020;4(4):478–92.32258944 10.1002/hep4.1479
114. Schwertheim S et al. Higher pNRF2, SOCS3, IRF3, and RIG1 tissue protein expression in NASH patients versus NAFL patients: pNRF2 expression is concomitantly Associated with elevated fasting glucose levels. J Pers Med, 2023. 13(7).
115. Nguyen TB DGAT1-Dependent lipid Droplet Biogenesis protects mitochondrial function during Starvation-Induced Autophagy Dev Cell 2017 42 1 9 e215 10.1016/j.devcel.2017.06.003 28697336
Nguyen TB, et al. DGAT1-Dependent lipid Droplet Biogenesis protects mitochondrial function during Starvation-Induced Autophagy. Dev Cell. 2017;42(1):9–e215.28697336 10.1016/j.devcel.2017.06.003
116. Qian H Autophagy in liver diseases: a review Mol Aspects Med 2021 82 100973 10.1016/j.mam.2021.100973 34120768
Qian H, et al. Autophagy in liver diseases: a review. Mol Aspects Med. 2021;82:100973.34120768 10.1016/j.mam.2021.100973
117. He A Acetyl-CoA derived from hepatic peroxisomal β-Oxidation inhibits autophagy and promotes steatosis via mTORC1 activation Mol Cell 2020 79 1 30 e424 10.1016/j.molcel.2020.05.007 32473093
He A, et al. Acetyl-CoA derived from hepatic peroxisomal β-Oxidation inhibits autophagy and promotes steatosis via mTORC1 activation. Mol Cell. 2020;79(1):30–e424.32473093 10.1016/j.molcel.2020.05.007
118. Fritz KS Mitochondrial acetylome analysis in a mouse model of alcohol-induced liver injury utilizing SIRT3 knockout mice J Proteome Res 2012 11 3 1633 43 10.1021/pr2008384 22309199
Fritz KS, et al. Mitochondrial acetylome analysis in a mouse model of alcohol-induced liver injury utilizing SIRT3 knockout mice. J Proteome Res. 2012;11(3):1633–43.22309199 10.1021/pr2008384
119. Han Y Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene Nat Commun 2019 10 1 623 10.1038/s41467-019-08585-4 30733434
Han Y, et al. Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene. Nat Commun. 2019;10(1):623.30733434 10.1038/s41467-019-08585-4
120. Tacke F Zimmermann HW Macrophage heterogeneity in liver injury and fibrosis J Hepatol 2014 60 5 1090 6 10.1016/j.jhep.2013.12.025 24412603
Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis. J Hepatol. 2014;60(5):1090–6.24412603 10.1016/j.jhep.2013.12.025
121. Wang Q XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression JHEP Rep 2022 4 11 100555 10.1016/j.jhepr.2022.100555 36185574
Wang Q, et al. XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression. JHEP Rep. 2022;4(11):100555.36185574 10.1016/j.jhepr.2022.100555
122. Hernández-Gea V Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues Gastroenterology 2012 142 4 938 46 10.1053/j.gastro.2011.12.044 22240484
Hernández-Gea V, et al. Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology. 2012;142(4):938–46.22240484 10.1053/j.gastro.2011.12.044
123. Kim KM Gα(12) overexpression induced by miR-16 dysregulation contributes to liver fibrosis by promoting autophagy in hepatic stellate cells J Hepatol 2018 68 3 493 504 10.1016/j.jhep.2017.10.011 29080810
Kim KM, et al. Gα(12) overexpression induced by miR-16 dysregulation contributes to liver fibrosis by promoting autophagy in hepatic stellate cells. J Hepatol. 2018;68(3):493–504.29080810 10.1016/j.jhep.2017.10.011
124. Liu Z Hsp27 chaperones FUS phase separation under the modulation of stress-induced phosphorylation Nat Struct Mol Biol 2020 27 4 363 72 10.1038/s41594-020-0399-3 32231288
Liu Z, et al. Hsp27 chaperones FUS phase separation under the modulation of stress-induced phosphorylation. Nat Struct Mol Biol. 2020;27(4):363–72.32231288 10.1038/s41594-020-0399-3
125. Ito T Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients Am J Transpl 2021 21 2 614 25 10.1111/ajt.16219
Ito T, et al. Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients. Am J Transpl. 2021;21(2):614–25.10.1111/ajt.16219
126. Jiao J Expression of STING is increased in monocyte-derived macrophages and contributes to liver inflammation in hepatic ischemia-reperfusion Injury Am J Pathol 2022 192 12 1745 62 10.1016/j.ajpath.2022.09.002 36174680
Jiao J, et al. Expression of STING is increased in monocyte-derived macrophages and contributes to liver inflammation in hepatic ischemia-reperfusion Injury. Am J Pathol. 2022;192(12):1745–62.36174680 10.1016/j.ajpath.2022.09.002
127. Lei Z cGAS-mediated autophagy protects the liver from ischemia-reperfusion injury independently of STING Am J Physiol Gastrointest Liver Physiol 2018 314 6 G655 67 10.1152/ajpgi.00326.2017 29446653
Lei Z, et al. cGAS-mediated autophagy protects the liver from ischemia-reperfusion injury independently of STING. Am J Physiol Gastrointest Liver Physiol. 2018;314(6):G655–67.29446653 10.1152/ajpgi.00326.2017
128. Ailenberg M Dynasore enhances the formation of mitochondrial antiviral signalling aggregates and endocytosis-independent NF-κB activation Br J Pharmacol 2015 172 15 3748 63 10.1111/bph.13162 25850711
Ailenberg M, et al. Dynasore enhances the formation of mitochondrial antiviral signalling aggregates and endocytosis-independent NF-κB activation. Br J Pharmacol. 2015;172(15):3748–63.25850711 10.1111/bph.13162
129. Ailenberg M ACTIVATION OF THE MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN (MAVS) FOLLOWING LIVER ISCHEMIA/REPERFUSION AND ITS EFFECT ON INFLAMMATION AND INJURY Shock 2022 58 1 78 89 10.1097/SHK.0000000000001949 35670454
Ailenberg M, et al. ACTIVATION OF THE MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN (MAVS) FOLLOWING LIVER ISCHEMIA/REPERFUSION AND ITS EFFECT ON INFLAMMATION AND INJURY. Shock. 2022;58(1):78–89.35670454 10.1097/SHK.0000000000001949
130. Zhou W cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing Mol Cell 2021 81 4 739 e7557 10.1016/j.molcel.2021.01.024 33606975
Zhou W, et al. cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing. Mol Cell. 2021;81(4):739–e7557.33606975 10.1016/j.molcel.2021.01.024
131. Saimaier K et al. Manganese Exacerbates ConA-Induced Liver Inflammation via the cGAS-STING Signaling Pathway Inflammation, 2023.
132. Frissen M Bidirectional role of NLRP3 during Acute and Chronic Cholestatic Liver Injury Hepatology 2021 73 5 1836 54 10.1002/hep.31494 32748971
Frissen M, et al. Bidirectional role of NLRP3 during Acute and Chronic Cholestatic Liver Injury. Hepatology. 2021;73(5):1836–54.32748971 10.1002/hep.31494
133. Ringelhan M The immunology of hepatocellular carcinoma Nat Immunol 2018 19 3 222 32 10.1038/s41590-018-0044-z 29379119
Ringelhan M, et al. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19(3):222–32.29379119 10.1038/s41590-018-0044-z
134. Chen R The role of cGAS-STING signalling in liver diseases JHEP Rep 2021 3 5 100324 10.1016/j.jhepr.2021.100324 34381984
Chen R, et al. The role of cGAS-STING signalling in liver diseases. JHEP Rep. 2021;3(5):100324.34381984 10.1016/j.jhepr.2021.100324
135. Du SS Radiation Therapy promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING activation Int J Radiat Oncol Biol Phys 2022 112 5 1243 55 10.1016/j.ijrobp.2021.12.162 34986380
Du SS, et al. Radiation Therapy promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING activation. Int J Radiat Oncol Biol Phys. 2022;112(5):1243–55.34986380 10.1016/j.ijrobp.2021.12.162
136. Liu Z RIG-I suppresses the migration and invasion of hepatocellular carcinoma cells by regulating MMP9 Int J Oncol 2015 46 4 1710 20 10.3892/ijo.2015.2853 25626059
Liu Z, et al. RIG-I suppresses the migration and invasion of hepatocellular carcinoma cells by regulating MMP9. Int J Oncol. 2015;46(4):1710–20.25626059 10.3892/ijo.2015.2853
137. Li Z JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis J Hematol Oncol 2022 15 1 161 10.1186/s13045-022-01381-6 36333807
Li Z, et al. JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis. J Hematol Oncol. 2022;15(1):161.36333807 10.1186/s13045-022-01381-6
138. Chao X Autophagy and liver cancer Clin Mol Hepatol 2020 26 4 606 17 10.3350/cmh.2020.0169 33053934
Chao X, et al. Autophagy and liver cancer. Clin Mol Hepatol. 2020;26(4):606–17.33053934 10.3350/cmh.2020.0169
139. Yang Y Dynamic transcriptomic m(6)a decoration: writers, erasers, readers and functions in RNA metabolism Cell Res 2018 28 6 616 24 10.1038/s41422-018-0040-8 29789545
Yang Y, et al. Dynamic transcriptomic m(6)a decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28(6):616–24.29789545 10.1038/s41422-018-0040-8
40. He ZJ Phase separation of RNF214 promotes the progression of hepatocellular carcinoma Cell Death Dis 2024 15 7 483 10.1038/s41419-024-06869-2 38969650
He ZJ, et al. Phase separation of RNF214 promotes the progression of hepatocellular carcinoma. Cell Death Dis. 2024;15(7):483.38969650 10.1038/s41419-024-06869-2
141. Liu X SIRT1 regulates N(6) -Methyladenosine RNA modification in Hepatocarcinogenesis by Inducing RANBP2-Dependent FTO SUMOylation Hepatology 2020 72 6 2029 50 10.1002/hep.31222 32154934
Liu X, et al. SIRT1 regulates N(6) -Methyladenosine RNA modification in Hepatocarcinogenesis by Inducing RANBP2-Dependent FTO SUMOylation. Hepatology. 2020;72(6):2029–50.32154934 10.1002/hep.31222
142. Wu Y Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity Nat Cancer 2023 4 3 382 400 10.1038/s43018-023-00522-1 36894639
Wu Y, et al. Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity. Nat Cancer. 2023;4(3):382–400.36894639 10.1038/s43018-023-00522-1
143. Zhang JZ Phase separation of a PKA Regulatory Subunit controls cAMP compartmentation and Oncogenic Signaling Cell 2020 182 6 1531 e154415 10.1016/j.cell.2020.07.043 32846158
Zhang JZ, et al. Phase separation of a PKA Regulatory Subunit controls cAMP compartmentation and Oncogenic Signaling. Cell. 2020;182(6):1531–e154415.32846158 10.1016/j.cell.2020.07.043
144. Bouchard JJ Cancer mutations of the tumor suppressor SPOP disrupt the formation of active, phase-separated compartments Mol Cell 2018 72 1 19 e368 10.1016/j.molcel.2018.08.027 30244836
Bouchard JJ, et al. Cancer mutations of the tumor suppressor SPOP disrupt the formation of active, phase-separated compartments. Mol Cell. 2018;72(1):19–e368.30244836 10.1016/j.molcel.2018.08.027
145. Boija A Klein IA Young RA Biomol Condensates Cancer Cancer Cell 2021 39 2 174 92 10.1016/j.ccell.2020.12.003
Boija A, Klein IA, Young RA. Biomol Condensates Cancer Cancer Cell. 2021;39(2):174–92.10.1016/j.ccell.2020.12.003
146. Liu S USP42 drives nuclear speckle mRNA splicing via directing dynamic phase separation to promote tumorigenesis Cell Death Differ 2021 28 8 2482 98 10.1038/s41418-021-00763-6 33731873
Liu S, et al. USP42 drives nuclear speckle mRNA splicing via directing dynamic phase separation to promote tumorigenesis. Cell Death Differ. 2021;28(8):2482–98.33731873 10.1038/s41418-021-00763-6
147. Chen S circVAMP3 drives CAPRIN1 phase separation and inhibits Hepatocellular Carcinoma by suppressing c-Myc translation Adv Sci (Weinh) 2022 9 8 e2103817 10.1002/advs.202103817 35072355
Chen S, et al. circVAMP3 drives CAPRIN1 phase separation and inhibits Hepatocellular Carcinoma by suppressing c-Myc translation. Adv Sci (Weinh). 2022;9(8):e2103817.35072355 10.1002/advs.202103817
148. Kiang KM Biomolecular condensates: hubs of Hippo-YAP/TAZ signaling in cancer Trends Cell Biol 2024 34 7 566 77 10.1016/j.tcb.2024.04.009 38806345
Kiang KM, et al. Biomolecular condensates: hubs of Hippo-YAP/TAZ signaling in cancer. Trends Cell Biol. 2024;34(7):566–77.38806345 10.1016/j.tcb.2024.04.009
149. Chakravarty AK Biomolecular Condensation: a New Phase in Cancer Research Cancer Discov 2022 12 9 2031 43 10.1158/2159-8290.CD-21-1605 35852417
Chakravarty AK, et al. Biomolecular Condensation: a New Phase in Cancer Research. Cancer Discov. 2022;12(9):2031–43.35852417 10.1158/2159-8290.CD-21-1605
150. Peng Q Phase separation in Cancer: from the impacts and mechanisms to treatment potentials Int J Biol Sci 2022 18 13 5103 22 10.7150/ijbs.75410 35982902
Peng Q, et al. Phase separation in Cancer: from the impacts and mechanisms to treatment potentials. Int J Biol Sci. 2022;18(13):5103–22.35982902 10.7150/ijbs.75410
151. Hou C PhaSepDB in 2022: annotating phase separation-related proteins with droplet states, co-phase separation partners and other experimental information Nucleic Acids Res 2023 51 D1 D460 5 10.1093/nar/gkac783 36124686
Hou C, et al. PhaSepDB in 2022: annotating phase separation-related proteins with droplet states, co-phase separation partners and other experimental information. Nucleic Acids Res. 2023;51(D1):D460–5.36124686 10.1093/nar/gkac783
152. Wang Y Dissolution of oncofusion transcription factor condensates for cancer therapy Nat Chem Biol 2023 19 10 1223 34 10.1038/s41589-023-01376-5 37400539
Wang Y, et al. Dissolution of oncofusion transcription factor condensates for cancer therapy. Nat Chem Biol. 2023;19(10):1223–34.37400539 10.1038/s41589-023-01376-5
153. Sun R Chemical probes for investigating protein liquid-liquid phase separation and aggregation Curr Opin Chem Biol 2023 74 102291 10.1016/j.cbpa.2023.102291 37004350
Sun R, et al. Chemical probes for investigating protein liquid-liquid phase separation and aggregation. Curr Opin Chem Biol. 2023;74:102291.37004350 10.1016/j.cbpa.2023.102291
154. Wang T Chemical-induced phase transition and global conformational reorganization of chromatin Nat Commun 2023 14 1 5556 10.1038/s41467-023-41340-4 37689690
Wang T, et al. Chemical-induced phase transition and global conformational reorganization of chromatin. Nat Commun. 2023;14(1):5556.37689690 10.1038/s41467-023-41340-4
155. Heymann F Tacke F Immunology in the liver–from homeostasis to disease Nat Rev Gastroenterol Hepatol 2016 13 2 88 110 10.1038/nrgastro.2015.200 26758786
Heymann F, Tacke F. Immunology in the liver–from homeostasis to disease. Nat Rev Gastroenterol Hepatol. 2016;13(2):88–110.26758786 10.1038/nrgastro.2015.200
156. Tilg H Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity Nat Metab 2021 3 12 1596 607 10.1038/s42255-021-00501-9 34931080
Tilg H, et al. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. Nat Metab. 2021;3(12):1596–607.34931080 10.1038/s42255-021-00501-9
157. Galasso L et al. Inflammatory response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: a double-edged Weapon. Int J Mol Sci, 2024. 25(13).
158. Pourbagheri-Sigaroodi A Immune landscape of hepatocellular carcinoma: from dysregulation of the immune responses to the potential immunotherapies Cell Biochem Funct 2024 42 5 e4098 10.1002/cbf.4098 39034646
Pourbagheri-Sigaroodi A, et al. Immune landscape of hepatocellular carcinoma: from dysregulation of the immune responses to the potential immunotherapies. Cell Biochem Funct. 2024;42(5):e4098.39034646 10.1002/cbf.4098
159. Heidegger S et al. RIG-I activation is critical for responsiveness to checkpoint blockade. Sci Immunol, 2019. 4(39).
160. Ruff KM Pappu RV AlphaFold and implications for intrinsically disordered proteins J Mol Biol 2021 433 20 167208 10.1016/j.jmb.2021.167208 34418423
Ruff KM, Pappu RV. AlphaFold and implications for intrinsically disordered proteins. J Mol Biol. 2021;433(20):167208.34418423 10.1016/j.jmb.2021.167208
161. Jin X Effects of pH alterations on stress- and aging-induced protein phase separation Cell Mol Life Sci 2022 79 7 380 10.1007/s00018-022-04393-0 35750966
Jin X, et al. Effects of pH alterations on stress- and aging-induced protein phase separation. Cell Mol Life Sci. 2022;79(7):380.35750966 10.1007/s00018-022-04393-0
